Cytosine compounds and a process for the production thereof
CA 2012096 C · Owner: Karimian, Khashayar · Inventors: Radatus, Bruno Konrad; Karimian, Khashayar
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of Formula I:, (see fig. I), wherein R1 is selected from the group comprising a trifluoromethyl group, a C1-C6 alkyl group and a C6-C9 aryl group, and R2 is selected from the group comprising hydrogen, trityl, methoxytrityl, dimethoxytrityl acetyl, a C2-C6 alkylacyl group, a C6-C9 arylacyl group allyl, 2,2,2-trichloroethyl, phosphates and salts thereof, tosyl and mesyl, and a process for the production thereof are provided. The compound of Formula I or the corresponding pharmaceutically acceptable salt (or the neutral form of the compound of Formula I) may then be converted to the corresponding compound of Formula V, or pharmaceutically acceptable salts thereof:, (see fig. V), …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 13, 1990 and granted October 28, 1997. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 13, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 13, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.